Bill
A 149
Bill A 149 ensures schools stock epinephrine auto-injectors, trains staff to manage allergic emergencies, and protects them from liability, enhancing student safety.
Bill A 149 aims to enhance the safety and health of students in schools by ensuring the availability and accessibility of epinephrine devices. The bill recognizes the critical role that epinephrine plays in treating severe allergic reactions (anaphylaxis) and seeks to establish protocols for schools to manage these emergencies effectively.
Epinephrine Device Availability: The bill mandates that all public and private schools maintain a supply of epinephrine auto-injectors on-site. This ensures that immediate treatment is available for students experiencing anaphylactic reactions.
Training Requirements: School personnel will be required to undergo training on how to recognize the signs of anaphylaxis and how to properly administer epinephrine devices. This training aims to empower staff to respond swiftly and effectively in emergencies.
Emergency Action Plans: Schools will be required to develop and implement emergency action plans that outline procedures for responding to anaphylactic emergencies, including the use of epinephrine devices.
Liability Protections: The bill includes provisions to protect school staff from liability when administering epinephrine in good faith during an emergency, encouraging prompt action without fear of legal repercussions.
Students: The primary beneficiaries of this bill are students with known allergies who are at risk of anaphylaxis. The availability of epinephrine devices can significantly improve their safety and response times during allergic reactions.
School Staff: Teachers and other school personnel will receive training and resources to manage allergic emergencies, enhancing their preparedness and confidence in handling such situations.
Parents and Guardians: Families of students with allergies can have increased peace of mind knowing that schools are equipped and prepared to handle potential allergic reactions.
Introduced Date: The bill was introduced on January 08, 2025, and has been referred to the Health Committee for further consideration.
Related Legislation: Bill A 149 is part of a broader legislative context, with several related bills from prior sessions (A 1582, A 8249, A 529, A 645, A 300, A 1855) that may address similar issues regarding health and safety in schools.
Bill A 149 represents a proactive approach to managing allergic reactions in school settings. By ensuring the availability of epinephrine devices and training for staff, the bill aims to create a safer environment for students with allergies, ultimately reducing the risk of severe health incidents in schools. The bill is currently under review by the Health Committee, and its progress will be closely monitored by stakeholders in the education and health sectors.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
